OAB-001 Potentiating T cell activity against multiple myeloma through SUMOylation inhibition Li Du1, Dennis Awuah1, Wei Liu2, En
Frontiers | Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities
Measuring M-Protein SPEP, UPEP Tests | Int'l Myeloma Fdn
Pathology Outlines - Monoclonal gammopathy testing
Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysis | PLOS ONE
Getting the Most Out of Your Treatment: Your Role in Achieving Desired Outcomes in the Patient Journey - CONQUER: the patient voice
Targets of biologic disease‐modifying antirheumatic drugs and risk of multiple myeloma - Calip - 2020 - International Journal of Cancer - Wiley Online Library
Frontiers | Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
Monoclonal gammopathy - Wikipedia
ICD-10 Code for Multiple myeloma- C90.0- Codify by AAPC
JCM | Free Full-Text | Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications
Myeloma Explained | Haematology | Oncology | onthewards
Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study | Scientific Reports
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge | Article
Pathology Outlines - Plasma cell myeloma (multiple myeloma)
Tech Support
Pathology Outlines - Plasma cell myeloma (multiple myeloma)
ICD-10-CM Index 2019
Multiple myeloma - Wikipedia
Cardiac amyloidosis: An underdiagnosed/underappreciated disease - ScienceDirect
ICD-10 International statistical classification of diseases and related health problems
